Bellerophon Therapeutics, Inc. (BLPH): Price and Financial Metrics

Bellerophon Therapeutics, Inc. (BLPH): $0.04

0.00 (4.72%)

POWR Rating

Component Grades








Add BLPH to Watchlist
Sign Up

Industry: Biotech




#48 of 393

in industry

BLPH Price/Volume Stats

Current price $0.04 52-week high $12.58
Prev. close $0.03 52-week low $0.03
Day low $0.03 Volume 176,800
Day high $0.04 Avg. volume 897,022
50-day MA $0.15 Dividend yield N/A
200-day MA $2.95 Market Cap 434.27K

BLPH Stock Price Chart Interactive Chart >


  • BLPH scores best on the Sentiment dimension, with a Sentiment rank ahead of 95.16% of US stocks.
  • The strongest trend for BLPH is in Value, which has been heading up over the past 103 days.
  • BLPH's current lowest rank is in the Stability metric (where it is better than 1.09% of US stocks).

BLPH Stock Summary

  • For BLPH, its debt to operating expenses ratio is greater than that reported by just 0.34% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, BELLEROPHON THERAPEUTICS INC's debt growth rate surpasses merely 0% of about US stocks.
  • In terms of volatility of its share price, BLPH is more volatile than 98.53% of stocks we're observing.
  • Stocks that are quantitatively similar to BLPH, based on their financial statements, market capitalization, and price volatility, are OGEN, BNTC, BYSI, DRRX, and SONN.
  • BLPH's SEC filings can be seen here. And to visit BELLEROPHON THERAPEUTICS INC's official web site, go to

BLPH Valuation Summary

  • In comparison to the median Healthcare stock, BLPH's price/sales ratio is 55.56% lower, now standing at 0.8.
  • BLPH's price/sales ratio has moved NA NA over the prior 105 months.

Below are key valuation metrics over time for BLPH.

Stock Date P/S P/B P/E EV/EBIT
BLPH 2023-10-06 0.8 0.8 -0.4 0.4
BLPH 2023-10-05 0.8 0.8 -0.4 0.5
BLPH 2023-10-04 0.8 0.8 -0.4 0.5
BLPH 2023-10-03 0.8 0.8 -0.4 0.4
BLPH 2023-10-02 0.9 0.9 -0.4 0.4
BLPH 2023-09-29 0.9 0.9 -0.4 0.4

BLPH Growth Metrics

    Its 3 year price growth rate is now at -91.57%.
  • Its 2 year net income to common stockholders growth rate is now at -2.83%.
  • Its year over year net income to common stockholders growth rate is now at 28.88%.
BLPH's revenue has moved down $0 over the prior 67 months.

The table below shows BLPH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0 -17.396 -19.087
2022-06-30 0 -17.972 -18.652
2022-03-31 0 -19.671 -17.936
2021-12-31 0 -22.821 -17.756
2021-09-30 0 -25.247 -21.489
2021-06-30 0 -24.577 -24.788

BLPH Price Target

For more insight on analysts targets of BLPH, see our BLPH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $25.00 Average Broker Recommendation 1.5 (Moderate Buy)

Bellerophon Therapeutics, Inc. (BLPH) Company Bio

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates are INOpulse, a pulsatile nitric oxide delivery device, which is in Phase III clinical trials for the treatment of pulmonary arterial hypertension; and in Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases and pulmonary hypertension associated with idiopathic pulmonary fibrosis. Bellerophon Therapeutics, Inc. was founded in 2009 and is founded in Warren, New Jersey.

BLPH Latest News Stream

Event/Time News Detail
Loading, please wait...

BLPH Latest Social Stream

Loading social stream, please wait...

View Full BLPH Social Stream

Latest BLPH News From Around the Web

Below are the latest news stories about BELLEROPHON THERAPEUTICS INC that investors may wish to consider to help them evaluate BLPH as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!

William White on InvestorPlace | July 28, 2023

Why Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?

Bellerophon Therapeutics (BLPH) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice.

William White on InvestorPlace | July 25, 2023

Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts

Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.

William White on InvestorPlace | July 25, 2023

MBLY Stock Alert: Morgan Stanley Restarts Mobileye Coverage

Mobileye (MBLY) stock is on the move Tuesday after Morgan Stanley analyst Adam Jonas renewed coverage of the company's shares.

William White on InvestorPlace | July 25, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning!

William White on InvestorPlace | July 25, 2023

Read More 'BLPH' Stories Here

BLPH Price Returns

1-mo 2.56%
3-mo N/A
6-mo -95.56%
1-year -96.08%
3-year -99.41%
5-year -99.75%
YTD -95.56%
2022 -70.97%
2021 -53.52%
2020 27.16%
2019 -56.29%
2018 -68.99%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!